Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04004494
Other study ID # RTS-008
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 1, 2019
Est. completion date December 31, 2023

Study information

Verified date May 2024
Source Ruijin Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Anatomical variations of pulmonary vessel may cause serious problems during pulmonary segmentectomy. Three-dimensional (3D)computed tomography (CT) presents 3D images of pulmonary vessels and the tracheobronchial tree and may help operative planning. Retrospective studies have identified the importance of 3-dimensional CT in the field of pulmonary segmentectomy. And the aim of this study is to compare the usefulness of 3-dimensional CT with standard chest CT in preoperative planning of video-assisted segmentectomy.


Description:

Lung cancer has been the most serious malignancy around the world which has the highest morbidity and mortality amount all the malignant tumors. Due to the wide spread of lung cancer screening, more and more early stage lung cancer patients have been diagnosed. Video-assisted segmentectomy is a standard surgical procedure in treating early stage peripheral non-small cell lung cancer (NSCLC). However, anatomical variations of pulmonary vessel may cause serious problems, for example unexpected bleed during surgery. Three-dimensional computed tomography (CT), which is reconstructed based on the standard chest CT image, presents 3D images of pulmonary vessels and the tracheobronchial tree and therefore helps operative planning. There are several retrospective studies addressed the importance of 3-dimensional CT in the field of pulmonary segmentectomy. And the aim of this multicenter randomized controlled trial is to compare the usefulness of 3-dimensional CT and standard chest CT in preoperative planning of video-assisted segmentectomy.


Recruitment information / eligibility

Status Completed
Enrollment 191
Est. completion date December 31, 2023
Est. primary completion date October 31, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Age older than 18 years; 2. Pulmonary nodules or ground glass opacification (GGO) found in chest CT examination, and conform with indications for segmentectomy: Peripheral nodule 0.8-2 cm with at least one of the following: i. Histology of adenocarcinoma in situ; ii. Nodule has =50% ground-glass appearance on CT; iii. Radiologic surveillance confirms a long doubling time (=400 days). Segmentectomy should achieve parenchymal resection margins =2 cm or = the size of the nodule. 3. Adequate cardiac function, respiratory function, liver function and renal function for anesthesia and VATS segmentectomy. 4. American Society of Anesthesiologists (ASA) score: Grade I-III. 5. Patients who can coordinate the treatment and research and sign the informed consent. Exclusion Criteria: 1. Patients with a significant medical condition which is thought unlikely to tolerate the surgery. For example, cardiac disease, significant liver and renal function disorder. 2. Patients with psychiatric disease who are expected lack of compliance with the protocol. 3. Patients have history of chest trauma or surgery on ipsilateral chest which may cause pleural adhesion.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
3D reconstruction
3-dimensional computed tomography reconstruction guided VATS segmentectomy

Locations

Country Name City State
China Union Hospital of Fujian medical university Fujian Fujian
China Guangdong General Hospital Guangdong Guangdong
China Ruijin Hospital, Shanghai JiaoTong University School of Medicine Shanghai Shanghai

Sponsors (3)

Lead Sponsor Collaborator
Ruijin Hospital Guangdong Provincial People's Hospital, Union hospital of Fujian Medical University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Other Total hospitalization expenditures cost in hospital postoperative in-hospital stay up to 30 days
Other Anatomical variations Rate of anatomical variation of segmental bronchus and pulmonary vessel in Chinese population During surgery
Primary operative time the time of operation During surgery
Secondary blood loss Amount of intraoperative blood loss During surgery
Secondary conversion rate the rate of conversion to open surgery in the operation During surgery
Secondary operative accident event the accident event happened in operative. For example, a segmentectomy is converted to a lobectomy During surgery
Secondary Incidence of postoperative complications mainly include: pneumonia, arrhythmia, incision infection, vocal cord paralysis, trachea cannula Postoperative in-hospital stay up to 30 days
Secondary Postoperative hospital stay length of stay in hospitalization Up to 24 weeks
Secondary Duration of chest tube placement Duration of chest tube placement Up to 4 weeks
Secondary 30-day mortality 30-day mortality after surgery Postoperative in-hospital stay up to 30 days
Secondary dissection of lymph nodes including overall lymph node count, number of stations dissected and number of lymph nodes in each lymph node station 2 weeks after surgery
Secondary Overall survival (OS) Up to the date of death of any causes since the date of randomization up to 60 months
Secondary Disease-free survival (DFS) Up to the date of disease recurrence since the date of randomization up to 60 months
Secondary Preoperative lung function forced expiratory volume at one second(FEV1) in litre, maximal voluntary ventilation (MVV) in litre Baseline
Secondary Postoperative lung function forced expiratory volume at one second(FEV1) in litre, maximal voluntary ventilation (MVV) in litre at the 3rd month after surgery
Secondary Incidence of change of surgical plan Surgical plan is made based of the image of standard chest computed tomography or three-dimensional computed tomography, the targeted segmental bronchus and pulmonary vessels are decided preoperatively. Change of surgical plan is recorded when the actually resected bronchus and vessels are different to those in the preoperative surgical plan During surgery
See also
  Status Clinical Trial Phase
Completed NCT04842578 - The Guidance of Thin Cross- Section of CT in Anatomic Segmentectomy N/A
Not yet recruiting NCT05525923 - OpalGenix (TS) - Personalized Postoperative Pain Management Following Thoracic Surgery in Adults
Recruiting NCT03227380 - Morphologic Study of the Intersegmental Plane After Fully Thoracoscopic Segmentectomy N/A
Active, not recruiting NCT02816671 - MicroCutter Assisted Thoracic Surgery Hemostasis Registry
Terminated NCT03192904 - Comparison of Energy Instruments and Stapling Device to Dissect Intersegmental Plane in Segmentectomy N/A
Completed NCT01775657 - Digital Versus Analog Pleural Drainage Following Pulmonary Resection N/A
Recruiting NCT05717803 - Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012) Phase 3
Completed NCT05350137 - Application of Carbon Dioxide for Identifying the Intersegmental Plane in Thoracoscopic Segmentectomy N/A
Completed NCT06132607 - 3D Lung Reconstructions Using Open-source Software for Lung Cancer Surgery N/A
Recruiting NCT05453721 - Effect and Long-Term Outcomes of Indocyanine Green Fluorescence Imaging Method Versus Modified Inflation-Deflation Method in Identification of Intersegmental Plane(IMPLANE-0529) N/A